TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL REGULATION OF TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR AND TISSUE-TYPE PLASMINOGEN-ACTIVATOR GENE-EXPRESSION IN HTC RAT HEPATOMA-CELLS BY GLUCOCORTICOIDS AND CYCLIC-NUCLEOTIDES

被引:52
作者
HEATON, JH
KATHJU, S
GELEHRTER, TD
机构
关键词
D O I
10.1210/me.6.1.53
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have reported previously that incubation of HTC rat hepatoma cells with the synthetic glucocorticoid dexamethasone causes a 90% decrease in tissue-type plasminogen activator (tPA) activity secondary to a 4-fold increase in plasminogen activator inhibitor-1 (PAI-1) mRNA accumulation. Dexamethasone also induces a modest and transient increase in tPA mRNA. The cyclic nucleotide analog 8-bromo-cAMP (cA) causes a greater than 50-fold increase in PA activity, the result of a 90% decrease in PAI-1 and a sustained 2-fold increase in tPA mRNA accumulation. Dexamethasone and cA in combination cause a 150-fold increase in PA activity, the result of an 80% decrease in PAI-1 and a synergistic 15-fold increase in tPA mRNA. To determine the mechanism of this complex hormonal regulation, we have examined rates of synthesis and decay of PAI-1 and tPA mRNAs. Here we report that dexamethasone induces a 5-fold increase in PAI-1 gene transcription and does not significantly alter PAI-1 message decay; PAI-1 mRNA has a half-life of about 4 h in both untreated and dexamethasone-treated cells. In contrast, cA regulates PAI-1 mRNA by both decreasing the rate of PAI-1 gene transcription by 60% and accelerating the rate of PAI-1 message decay. Regulation of tPA by cA, both alone and in combination with dexamethasone, occurs primarily at the level of transcription. Dexamethasone and cA-induced tPA mRNA has a half-life of 2.75 h; tPA mRNA degradation is significantly inhibited by either cycloheximide or actinomycin-D. Transcriptional regulation of PAI-1 by dexamethasone appears to be a direct effect and does not require concomitant protein synthesis. In contrast, the cA-induced decrease in transcription is blocked by cycloheximide, and the cA-induced increase in PAI-1 mRNA decay is blocked by actinomycin-D, suggesting that these are secondary effects.
引用
收藏
页码:53 / 60
页数:8
相关论文
共 54 条
[1]   PLASMINOGEN-ACTIVATOR INHIBITORS - HORMONALLY REGULATED SERPINS [J].
ANDREASEN, PA ;
GEORG, B ;
LUND, LR ;
RICCIO, A ;
STACEY, SN .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1990, 68 (01) :1-19
[2]   HORMONAL-REGULATION OF EXTRACELLULAR PLASMINOGEN ACTIVATORS AND MR - 54000 PLASMINOGEN-ACTIVATOR INHIBITOR IN HUMAN NEOPLASTIC CELL-LINES, STUDIED WITH MONOCLONAL-ANTIBODIES [J].
ANDREASEN, PA ;
CHRISTENSEN, TH ;
HUANG, JY ;
NIELSEN, LS ;
WILSON, EL ;
DANO, K .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1986, 45 (2-3) :137-147
[3]   PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 BIOSYNTHESIS AND MESSENGER-RNA LEVEL ARE INCREASED BY DEXAMETHASONE IN HUMAN FIBROSARCOMA CELLS [J].
ANDREASEN, PA ;
PYKE, C ;
RICCIO, A ;
KRISTENSEN, P ;
NIELSEN, LS ;
LUND, LR ;
BLASI, F ;
DANO, K .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :3021-3025
[4]  
Ausubel F, 1988, CURRENT PROTOCOLS MO
[5]   PARADOXICAL EFFECTS OF GLUCOCORTICOIDS ON REGULATION OF PLASMINOGEN-ACTIVATOR ACTIVITY OF RAT HEPATOMA-CELLS [J].
BAROUSKIMILLER, PA ;
GELEHRTER, TD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (07) :2319-2322
[6]  
BAROUSKIMILLER PA, 1983, CANCER RES, V43, P5922
[7]   GENE-REGULATION BY STEROID-HORMONES [J].
BEATO, M .
CELL, 1989, 56 (03) :335-344
[8]  
BERNATH VA, 1990, J BIOL CHEM, V265, P18219
[9]   AN INDUCIBLE CYTOPLASMIC FACTOR (AU-B) BINDS SELECTIVELY TO AUUUA MULTIMERS IN THE 3' UNTRANSLATED REGION OF LYMPHOKINE MESSENGER-RNA [J].
BOHJANEN, PR ;
PETRYNIAK, B ;
JUNE, CH ;
THOMPSON, CB ;
LINDSTEN, T .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (06) :3288-3295